HIGHLIGHTS
- who: Am. J. Trop. Med. et al. from the DepartmentTanta University have published the paper: Remdesivir Ef cacy in COVID-19 Treatment: A Randomized Controlled Trial, in the Journal: (JOURNAL) of December/19,/2020
- what: The duration of hospitalization reported in the control group in this study (median 5 16 days) was comparable to the results of a systematic review that analyzed length of hospital stay of COVID-19 patients mainly in China (median 5 14 days).16 Low mortality rates reported in this study reproduce the finding of a systematic review by Bansal et_al22 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.